If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
787.00    -13.00 (-1.63%)
Bid:
787.00
Ask:
788.50
Spread: 1.50 (0.191%)
Market Cap: £890.19m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Update on share buyback extension

1 Jul 2026 07:00

RNS Number : 4677K
Fevertree Drinks PLC
01 July 2026
 

 

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Update on share buyback extension

In its FY26 AGM Trading Statement published on 9 June 2026, Fever-Tree announced a £30 million extension (the "Extension") of the Company's share buyback programme announced on 2 February 2026 (the "Programme"), taking the total programme maximum consideration to £60 million. The Company today announces the commencement the Extension which is to be conducted until 31 December 2026 to buyback ordinary shares of a nominal value of 0.25 pence each (the "Shares").

Fever-Tree has amended its agreement with Investec Bank plc ("Investec") pursuant to which Investec will continue to carry out on-market purchases of Shares on its behalf and to make trading decisions independently of the Company. Save as set out herein, the Programme will otherwise continue to be subject to the same parameters set out in the Company's announcement of 2 February 2026.

Investec will purchase the Shares as principal and simultaneously be deemed to execute sales to the Company of any Shares so purchased in accordance with the terms of their engagement.

Any purchase of Shares under the Programme moving forwards will be executed in accordance with certain pre-set parameters and in accordance with the Company's existing general authority to repurchase Shares granted by its shareholders at the annual general meeting held on 9 June 2026 and any subsequent general authorities granted by the Company's shareholders, the Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and UKLR 9.6.2. The Company may repurchase up to 25% of the average daily trading volume in the Shares in the 20 trading days preceding the date on which a buy-back of Shares is carried out.

 

 For more information please contact:

Investor queries

Steve Nightingale, Investor Relations Director (Interim) steve.nightingale@fever-tree.com I +44 (0) 7951 849 564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0) 770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin +44 (0)20 7597 5970 | James Hopton +44 (0) 20 7597 2046

Corporate Broker - Jefferies International Limited

Ed Matthews +44 (0) 20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233

 

Notes to the Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers by retail sales value, with distribution to over 95 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDIFMSEMSEFM
Date   Source Headline
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20255:22 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20253:35 pmRNSDirector/PDMR Shareholding
17th Oct 20251:19 pmRNSResults of General Meeting
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20254:25 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20253:06 pmRNSTR-1: Notification of major holdings
1st Oct 20258:27 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20259:39 amRNSHolding(s) in Company
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 202512:03 pmRNSDirector/PDMR Shareholding
11th Sep 20258:00 amRNSProposed Share Premium Cancellation
11th Sep 20257:00 amRNSFY25 Interim Results to 30 June 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.